Search results
Scilex secures FDA nod for Gloperba gout treatment launch By Investing.com
Investing.com· 2 hours agoScilex Holding Company (NASDAQ:SCLX) announced today that it has received FDA approval to commence...
Vanda Pharmaceuticals Receives Another Takeover Proposal, Considers $466M Deal - Vanda Pharma...
Benzinga· 6 hours agoIn May, Cycle launched its sixth drug product in the U.S. market. In April, Vanda rejected Future Pak LLC’s proposal of $7.25 – $7.75 per share, saying it significantly undervalued the company ...
West Pharmaceutical Services, Inc. (NYSE:WST): The Best Dividend Aristocrat Stock According to...
Insider Monkey via Yahoo Finance· 3 hours agoWe recently compiled the list of 25 Best Dividend Aristocrats Stocks According to Analysts. Since...
Ani Pharmaceuticals CFO sells shares worth over $317k By Investing.com
Investing.com· 10 hours agoANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has reported a significant transaction involving its Senior...
Federal Circuit Upholds Rifaximin Patent Rulings, Affirms ANDA Approval Restrictions
The National Law Review· 3 hours agoIn Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals, Inc. 2023-1952 (Fed. Cir. April 11,...
FDA Declines Approval Of MDMA As Treatment For PTSD
International Business Times· 1 day agoThe Food and Drug Administration has declined to recommend approval for the use of MDMA, more popularly known as molly or ecstasy, to treat...
Cheaper Ozempic Alternatives Are Out There. Be Wary of Fakes and Fraudsters.
The Wall Street Journal· 9 hours agoMillions of people are taking Ozempic, Wegovy or Mounjaro for weight loss. Compounded drugs are...
EXCLUSIVE: Adial Pharmaceuticals Starts Patient Dosing In Pharmacokinetics Study Of AD04 For Alcohol...
Benzinga via Yahoo Finance· 1 day agoWednesday, Adial Pharmaceuticals Inc. (NASDAQ:ADIL) announced that the first patient had been dosed...
Be Bio’s haemophilia B treatment gains FDA orphan drug status
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe orphan drug designation reinforces the potential of this therapy and underscores the need for...
Why Is Rocket Pharmaceuticals (RCKT) Down 4.8% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 day agoWill the recent negative trend continue leading up to its next earnings release, or is Rocket ...